Literature DB >> 11039673

Hypersensitivity to mosquito bites is not an allergic disease, but an Epstein-Barr virus-associated lymphoproliferative disease.

S Ishihara1, R Yabuta, Y Tokura, K Ohshima, S Tagawa.   

Abstract

Recently, we showed that 5 cases of hypersensitivity to mosquito bites (HMB) concealed the clonal lymphoproliferation of Epstein-Barr viral (EBV) DNA-positive natural killer (NK) cells. Although the symptoms of HMB have been supposed to derive from Arthus phenomenon, it has become apparent that this unique disorder has the potential to develop into so-called malignant histiocytosis (MH) or related disorders. Accordingly, the criteria for MH have been changed, and a newer diagnostic name, hemophagocytic syndrome, has been described as being associated with viral infection or leukemia/lymphoma. We previously reported that biopsy specimens taken from skin lesions demonstrated infiltration of lymphocytes bearing the phenotype of NK cells. In this study, we found that skin lesions exhibited infiltration of atypical lymphocytes around the small vessels, resembling angiocentric lymphoma, and that these infiltrating cells were positive for EBER-1 by in situ hybridization. These findings support the concept that HMB is the most important manifestation of a certain type of lymphoproliferative disease that presents with an intense local skin reaction and high fever following mosquito bites, and whose essence is the lymphoproliferation of EBV DNA-positive NK cells.

Entities:  

Mesh:

Year:  2000        PMID: 11039673

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  6 in total

1.  Mantle cell lymphoma presenting with exaggerated skin reaction to insect bites.

Authors:  Kavita Darji; Emily Bahram-Ahi; Maulik Dhandha; Mary Guo
Journal:  BMJ Case Rep       Date:  2019-03-21

2.  Atypical hypersensitivity to mosquito bites without natural killer cell proliferative disease in an adult patient.

Authors:  Takaaki Konuma; Kaoru Uchimaru; Rieko Sekine; Nobuhiro Ohno; Yasushi Soda; Akira Tomonari; Jun Ooi; Fumitaka Nagamura; Satoshi Takahashi; Tohru Iseki; Naoki Oyaizu; Arinobu Tojo; Shigetaka Asano
Journal:  Int J Hematol       Date:  2005-12       Impact factor: 2.490

3.  Epidemiologic overview of malignant lymphoma.

Authors:  Jooryung Huh
Journal:  Korean J Hematol       Date:  2012-06-26

4.  A randomised, double-blind pilot study of enzyme-potentiated desensitisation for prophylaxis of large local reactions to mosquito bites.

Authors:  S Berkovitz; N Hill; M Radcliffe; G Ambler
Journal:  J Allergy (Cairo)       Date:  2012-03-22

Review 5.  Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorders.

Authors:  Qingqing Cai; Kailin Chen; Ken H Young
Journal:  Exp Mol Med       Date:  2015-01-23       Impact factor: 8.718

Review 6.  The Global Landscape of EBV-Associated Tumors.

Authors:  Claire Shannon-Lowe; Alan Rickinson
Journal:  Front Oncol       Date:  2019-08-06       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.